Drug Kinetics and CRRT

24
Drug Kinetics and CRRT: Parameters and Principles Morgan R. Cole, Pharm.D., BCPS Manager, HDVCH Pharmacy Services Clinical Pharmacy Specialist, Pediatric Critical Care

Transcript of Drug Kinetics and CRRT

Page 1: Drug Kinetics and CRRT

Drug Kinetics and CRRT: Parameters and Principles

Morgan R. Cole, Pharm.D., BCPS

Manager, HDVCH Pharmacy Services

Clinical Pharmacy Specialist,

Pediatric Critical Care

Page 2: Drug Kinetics and CRRT

Objectives

Describe CRRT principles Understand basic pharmacokinetic (Pk)

parameters Describe CRRT principles and effects on Pk Describe variances in Pk parameters

Critically ill Pediatrics & Neonates

Understand assumptions to estimate dosing regimens in pediatric CRRT

Page 3: Drug Kinetics and CRRT

CRRT Principles

Page 4: Drug Kinetics and CRRT

CRRT Principles

Heparin Anticoagulation Citrate Anticoagulation

Acid Citrate Dextrose – Anticoagulation (ACD-A)

Calcium Chloride Replacement Convective Clearance

Hemofiltration ~ Ultrafiltration Filter Replacement Fluid (FRF)

Diffusive Clearance Hemodialysis Dialysate

Page 5: Drug Kinetics and CRRT
Page 6: Drug Kinetics and CRRT

CRRT Principles

Usual circuit priming volume ~ 100-150mL Blood, Saline, & Albumin

Usual Blood Flow Rate

~ 3-5mL/kg/min

Tubing and Membrane Filter impact Adsorption

Adapted with permission from: Gambro Training Manual 1 and 2 Slides from Gambro Training package Last Update: February, 2008

Page 7: Drug Kinetics and CRRT
Page 8: Drug Kinetics and CRRT

Ultrafiltration

Adapted with permission from: Gambro Training Manual 1 and 2 Slides from Gambro Training package Last Update: February, 2008

Movement of fluid through a semi-permeable membrane caused by a pressure gradient

Positive, negative and osmotic pressure from non-permeable solutes

Page 9: Drug Kinetics and CRRT

Convective Clearance

Movement of solutes with water flow, “solvent drag”.

The more fluid moved through a semi-permeable membrane, the more solutes that are removed.

Replacement Fluid is used to create convection

Adapted with permission from: Gambro Training Manual 1 and 2 Slides from Gambro Training package Last Update: February, 2008

Page 10: Drug Kinetics and CRRT
Page 11: Drug Kinetics and CRRT

Diffusive Clearance

Movement of solutes from an area of higher concentration to an area of lower concentration.

Dialysate is used to create a concentration gradient across a semi-permeable membrane.

Adapted with permission from: Gambro Training Manual 1 and 2 Slides from Gambro Training package Last Update: February, 2008

Page 12: Drug Kinetics and CRRT
Page 13: Drug Kinetics and CRRT

Pharmacokinetic Parameters

Page 14: Drug Kinetics and CRRT

CRRT Impact on Kinetic Parameters

Usual circuit priming volume ~ 100-150mL Increases Volume of Distribution (Vd) Usual adult blood volume ~5000mL (0.07L/kg or 70mL/kg) Usual pediatric blood volume ~80mL/kg

Tubing binds drug Increases Vd Adsorption

Membrane Filter binds drug by “Gibbs-Donnan Effect” Increases Vd Adsorption

Page 15: Drug Kinetics and CRRT

CRRT Impact on Kinetic Parameters

Usual Blood Flow Rate ~ 3-5mL/kg/min Higher the rate leads to increased Clearance (Cl)

Ultrafiltrate Rate ~ Filter Replacement Fluid (FRF) Rate if the patient is kept in even fluid balance ~ 35-40mL/kg/hr (2.5L/m2/hr) Higher the rate leads to increased Cl

Dialysate Rate ~ 35-40mL/kg/hr (2.5L/m2/hr) Higher the rate leads to increased Cl

Page 16: Drug Kinetics and CRRT

Sample sieving coefficients (S)

Medication S

Gentamicin ~0.8

Tobramycin ~0.8

Amikacin ~0.9

Ceftazidime ~0.85

Cefepime ~0.85

Imipenem ~0.8

Meropenem ~0.8

Medication S

Levofloxacin ~0.8

Moxifloxacin ~0.85

Ciprofloxacin ~0.75

Pip / Tazo ~>1

Linezolid ~0.8

Daptomycin ~0.15

Vancomycin ~0.7Adapted from Golper, Dialysis Transpl 1993;22:185-188DelDot, Br J Clin Pharmacol 2004;58:3,259-268Malone, Antimicrobial Agents and Chemotherapy 2001;3148-3155Mariat, Crit Care 2006;10:1,R26Fuhrmann, Journal of Antimicrobial Chemotherapy 2004;54,780-784Guenter, Pharmacotherapy 2002;2:175-83Tegeder, Antimicrobial Agents and Chemotherapy 1997;41(12):2640-2645

Valtonen, Journal of Antimicrobial Chemotherapy 2001;48,881-885Valtonen, Journal of Antimicrobial Chemotherapy 2000;45,701-704Kraft, Pharmacotherapy 2003;23(8):1071-1075Churchwell, Blood Purif 2006;24(5-6):548-554

Page 17: Drug Kinetics and CRRT

CRRT Impact on Kinetic Parameters

Combined hemofiltration plus dialysis (Cldf) Convective Clearance (Filter Replacement Fluid (FRF))

Diffusive Clearance (Dialysate)

Cldf = Qf * S + Qd * Sd

Native clearance must be taken into account if the patient maintains renal function despite CRRT support

Page 18: Drug Kinetics and CRRT

Convective + Diffusive Clearance

Ultrafiltrate Rate ~

Filter Replacement Fluid (FRF) Rate

~ 35-40mL/kg/hr

(2.5L/m2/hr)

Dialysate Rate

~ 35-40mL/kg/hr

(2.5L/m2/hr)

Page 19: Drug Kinetics and CRRT
Page 20: Drug Kinetics and CRRT

Clinical Pearls

Medications unaffected by CRRT Ceftriaxone Metronidazole Clindamycin Lansoprazole Pantoprazole Cyclosporin Phenytoin

Page 21: Drug Kinetics and CRRT

Clinical Pearls

Due to extracorporeal clearance provided by CRRT remember to hold the following if CRRT circuit goes down and consult the primary service /nephrology service Total Parenteral Nutrition / Enteral Nutrition Antibiotics except ceftriaxone, clindamycin,

metronidazole Potassium, and Phosphorus supplementation H2 receptor antagonists

Page 22: Drug Kinetics and CRRT

Clinical Pearls

Due to extracorporeal clearance provided by CRRT remember to monitor closely for toxicity + reduce the dose for the following if CRRT circuit goes down and consult the primary service /nephrology service Sedation (Midazolam, Lorazepam, Fentanyl, & Morphine) Pressors (Norepinephrine, Epinephrine, & Dopamine) Inotropes (Milrinone, Dobutamine, & Epinephrine)

If a new circuit is initiated, a reloading phase will occur until complete adsorption occurs and a new steady state with the circuit is reached.

Page 23: Drug Kinetics and CRRT

Summary

Understand CRRT principles Ultrafiltration / Convective vs Diffusive Clearance

Understand basic pharmacokinetic (Pk) parameters Vd / Pb / Cl / t1/2

Describe variances in Pk parameters Critically ill Pediatrics & Neonates

Understand CRRT principles and effects on Pk Adsorption / Vd / Cl

Understand assumptions to estimate dosing regimens in pediatric CRRT Pb / MW / S / Sd / Clf / Cld / Cldf

Page 24: Drug Kinetics and CRRT

References

Gambro Renal Products, Intensive Care Division, 14143 Denver West Parkway Lakewood, Co.  80401

Golper, Dialysis Transpl 1993;22:185-188 DelDot, Br J Clin Pharmacol 2004;58:3,259-268 Malone, Antimicrobial Agents and Chemotherapy 2001;3148-3155 Mariat, Crit Care 2006;10:1,R26 Fuhrmann, Journal of Antimicrobial Chemotherapy 2004;54,780-

784 Guenter, Pharmacotherapy 2002;2:175-83 Tegeder, Antimicrobial Agents and Chemotherapy

1997;41(12):2640-2645 Valtonen, Journal of Antimicrobial Chemotherapy 2001;48,881-885 Valtonen, Journal of Antimicrobial Chemotherapy 2000;45,701-704 Kraft, Pharmacotherapy 2003;23(8):1071-1075 Churchwell, Blood Purif 2006;24(5-6):548-554